We sought to explore whether adding kidney function biomarkers based on creatinine (eGFRCr), cystatin C (eGFRCys) or a combination of the two (eGFRCr-Cys) could improve risk stratification for stroke and major bleeding, and whether there were sex differences in any additive value of kidney function biomarkers.
SHE-ROCKS
See full text: Sex differences in associations between creatinine and cystatin C-based kidney function measures with stroke and major bleeding